Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor

Journal of the National Cancer Institute

Volumn 93, Issue 22, 2001, Pages 1698-1703

  Ravenel, Jason D ^a   Broman, Karl W ^b   Perlman, Elizabeth J ^a   Niemitz, Emily L ^a   Jayawardena, Tilanthi M ^a   Bell, Daphne W ^c   Haber, Daniel A ^c   Uejima, Hiroshi ^a   Feinberg, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SOMATOMEDIN B;

ADULT; AGE; ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EXAMINATION; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; KIDNEY; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

EID: 0035930134     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.22.1698     Document Type: Article

References (49)

1. Relaxation of imprinted genes in human cancer
2. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour
3. Genomic imprinting, DNA methylation, and cancer
4. Genomic Imprinting and cancer
5. Loss of imprinting in hepatoblastoma
6. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting
7. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
8. Loss of imprinting of IGF2 in Ewing's sarcoma
9. Insulin-like growth factor II in uterine smooth-muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata
10. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19
11. Loss of H19 imprinting in esophageal cancer
12. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease
13. Loss if imprinting in choriocarcinoma
14. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors
15. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues
16. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
17. Insulin-like growth factor II mRNA expression in human breast cancer
18. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors
19. Insulin-like growth factor II-mediated proliferation of human neuroblastoma
20. Insulin-like growth factor-II: Possible local growth factor in pheochromocytoma
21. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
22. IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line
23. Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells
24. Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor
25. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor
26. Mutation and cancer: A model for Wilms' tumor of the kidney
27. Hot-stop PCR: A simple and general assay for linear quantitation of allele ratios
28. The new S language
29. Hereditary cancer, oncogenes, and antioncogenes
30. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour
31. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells
32. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11
33. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: A preliminary analysis
34. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript
35. KIP2 mutation in Beckwith-Wiedemann syndrome
36. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome
37. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from human chromosome 11
38. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour
39. Loss of imprinting of the insulin-like growth factor II gene in renal cell cancer
40. mRNA quantification by real time TaqMan polymerase chain reaction: Validation and comparison with RNase protection
41. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor
42. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour
43. A third Wilms' tumor locus on chromosome 16q
44. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11
45. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome
46. Epidemiological features of Wilms' tumor: Results of the National Wilms' Tumor Study
47. Age distribution of Wilms' tumor: Report from the National Wilms' tumor study
48. Wilms tumour and other childhood renal tumours. 2001
49. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling